Study record

Evaluation of vascular peroxidase 1, humanin, MOTS-c and miR-200c expression levels in untreated preeclampsia patients

Coskun E, Ekmekci OB, Gungor Z et al. · Mol Biol Rep · 2024

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured lower serum MOTS-c in women with untreated preeclampsia than in controls, alongside higher endoglin, VPO1 and miR-200c and no significant difference in humanin.

Limitations

Sample sizes are not reported and blood was sampled at one time point before treatment; correlations cannot establish direction; the MOTS-c result differs from other preeclampsia reports.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedSerum endoglin, VPO1, humanin, MOTS-c and miR-200c in untreated preeclamptic pregnancies and control pregnancies
Populationpregnant women with untreated preeclampsia and control pregnant women
DesignCase-control study
Sample size as reportedNot reported
Control groupcontrol pregnant women
Route (data field only)Not reported
Endpoints measuredserum MOTS-c; serum humanin; VPO1; endoglin; miR-200c
Pathways measuredOxidative stress
Research areasPregnancy · Cardiovascular
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Not reported
Controls
Appropriate
Outcome validity
Exploratory
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.